Detalhe da pesquisa
1.
Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies.
Cancers (Basel)
; 14(5)2022 Feb 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35267477
2.
A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic.
Clin Transl Radiat Oncol
; 30: 50-59, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34226880
3.
Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004).
Eur J Cancer
; 103: 249-258, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30286418
4.
Adverse drug reactions as cause of admission to hospital: only part of the picture was reported for aspirin.
BMJ
; 329(7463): 459; author reply 460, 2004 Aug 21.
Artigo
Inglês
| MEDLINE | ID: mdl-15321918